| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) has 16 insiders with recent SEC Form 4 filings, including 0 buys and 73 sells. UTHR is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | Rothblatt Martine A | 66.0K | $35.41M | - |
| VP | Mahon Paul A | 44.5K | $23.88M | - |
| CEO | 40.5K | $21.74M | -28,500 | |
| VP | 33.5K | $17.98M | - | |
| CFO | Edgemond James | 19.9K | $10.67M | - |
Buys and sells only